Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Ulcerative Colitis
NCT02390726Phase 1Unknown
- Sponsor
- The University of Vermont
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fecal microbiome transplant in ulcerative colitis (UC) (2 arms), sponsored by The University of Vermont. Primary endpoints: Endoscopic Stages of the Colon Pre/Post FMT at 2 years, Asses Biologic Inflammatory Markers at 2 years and 1 more. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02390726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390726.